Allianz Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-41,732
Closed -$470K 2021
2025
Q2
$470K Sell
41,732
-26,809
-39% -$246K ﹤0.01% 1838
2025
Q1
$649K Buy
68,541
+22,514
+49% +$227K ﹤0.01% 1800
2024
Q4
$518K Buy
46,027
+11,983
+35% +$211K ﹤0.01% 1853
2024
Q3
$963K Buy
34,044
+12,436
+58% +$321K ﹤0.01% 1642
2024
Q2
$413K Buy
+21,608
New +$552K ﹤0.01% 1893
2020
Q2
Sell
-182,866
Closed -$993K 2430
2020
Q1
$993K Buy
182,866
+34,210
+23% +$306K ﹤0.01% 1803
2019
Q4
$1.34M Sell
148,656
-4,455
-3% -$36.2K ﹤0.01% 2065
2019
Q3
$1.1M Buy
153,111
+21,192
+16% +$152K ﹤0.01% 2084
2019
Q2
$1.05M Buy
131,919
+76,374
+137% +$904K ﹤0.01% 2121
2019
Q1
$699K Sell
55,545
-3,517
-6% -$55.7K ﹤0.01% 2213
2018
Q4
$1.18M Buy
59,062
+43,108
+270% +$997K ﹤0.01% 1964
2018
Q3
$453K Buy
15,954
+3,248
+26% +$77.5K ﹤0.01% 2399
2018
Q2
$267K Hold
12,706
﹤0.01% 2502
2018
Q1
$181K Buy
+12,706
New +$182K ﹤0.01% 2582

Other funds holding EVH

Allianz Asset Management's EVH Position: Q3 2025 in Review

Allianz Asset Management sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 41,732 shares — an estimated $470K sold.

Allianz Asset Management first reported a position in EVH in Q1 2018 and held it in 14 quarters. The position peaked at $1.34M in Q4 2019. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Allianz Asset Management reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Allianz Asset Management sold 41,732 Evolent Health shares in Q3 2025, an estimated $470K.
  • Allianz Asset Management first reported a position in Evolent Health in Q1 2018 and held it in 14 quarters.
  • Allianz Asset Management's Evolent Health position peaked at $1.34M in Q4 2019.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Allianz Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.